Malin Life Sciences Holdings Ltd
CIK 1685138 · last filed 2025-01-10
Malin Life Sciences Holdings Ltd is a corporate insider who has filed 9 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for PSTX, was dated Jan 10, 2025. Across all open-market trades the lifetime net is +$28.7M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
9
$28.67M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Poseida Therapeutics, Inc. (PSTX) Delisted | 10%+ Owner | 0 | $9.50 | $0 | $11.07M | 8 | 2025-01-10 |
| Novan, Inc. (NOVN) Delisted | 10%+ Owner | 1,823,485 | $0.09 | $171.6K | $17.60M | 1 | 2016-09-28 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-10 | Poseida Therapeutics, Inc. (PSTX) Delisted | U | −11,835,673 | $0 | EDGAR |
| 2022-08-10 | Poseida Therapeutics, Inc. (PSTX) Delisted | Buy (P) | +2,150,000 | $7.53M | EDGAR |
| 2021-12-07 | Poseida Therapeutics, Inc. (PSTX) Delisted | Buy (P) | +1,828 | $12.6K | EDGAR |
| 2021-12-02 | Poseida Therapeutics, Inc. (PSTX) Delisted | Buy (P) | +51,253 | $351.2K | EDGAR |
| 2021-11-29 | Poseida Therapeutics, Inc. (PSTX) Delisted | Buy (P) | +39,362 | $269.0K | EDGAR |
| 2021-11-23 | Poseida Therapeutics, Inc. (PSTX) Delisted | Buy (P) | +25,729 | $181.6K | EDGAR |
| 2021-11-18 | Poseida Therapeutics, Inc. (PSTX) Delisted | Buy (P) | +379,376 | $2.73M | EDGAR |
| 2020-07-15 | Poseida Therapeutics, Inc. (PSTX) Delisted | Conv (C) | +18,376,250 | $0 | EDGAR |
| 2016-09-28 | Novan, Inc. (NOVN) Delisted | Mixed | +5,246,970 | $17.60M | EDGAR |